SLC5A2 and chronic kidney disease: In addition, SGLT2 inhibitors are recommended for treating adults with CKD with eGFR ≥20 ml/min/1.73m2 and urine ACR ≥200 mg/g, or heart failure, irrespective of level of albuminuria [1].